← Back to Search

Other

lyophilized blueberry supplement for Alzheimer's Disease

N/A

Waitlist Available

Led By Murali Doraiswamy, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 weeks

Awards & highlights

Study Summary

This trial will study the effects of blueberries on six blood biomarkers related to cognitive impairment and brain health.

Eligible Conditions

Alzheimer's Disease
Mild Cognitive Impairment

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in blood Amyloid beta 40/42 as measured by blood biomarker assay

Change in blood Neurofilament light (NfL) levels as measured by blood biomarker assay

Change in blood glial fibrillary acidic protein (GFAP) levels as measured by blood biomarker assay

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Blueberry supplementationExperimental Treatment1 Intervention

All participants will receive 18 grams lyophilized blueberry supplement mixed with water twice daily for 12 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

lyophilized blueberry supplement

2022

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,363 Previous Clinical Trials

3,420,474 Total Patients Enrolled

U.S. Highbush Blueberry CouncilOTHER

17 Previous Clinical Trials

1,051 Total Patients Enrolled

Murali Doraiswamy, MDPrincipal InvestigatorDuke University

4 Previous Clinical Trials

512 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What requirements must be met to participate in this trial?

"Candidates that meet the criteria of being between 55 and 85 years old and having Alzheimer's disease can apply to be part of this medical trial. The team is hoping to locate 12 eligible patients for participation."

Answered by AI

How many participants have been enrolled in this clinical trial?

"Affirmative. According to clinicaltrials.gov, the trial is in need of participants and was first registered on February 21st 2022 with its last update made around the same time. 12 individuals are required from one site for this study."

Answered by AI

Are there vacancies for participants of this medical experiment?

"Indeed, evidence hosted on clinicaltrials.gov verifies that registration for this medical trial is ongoing. It was initially posted in February 21st 2022 and last amended the same day; it seeks to recruit 12 individuals from a single location."

Answered by AI

Does this trial accept participants of all ages, particularly those under 25?

"To be eligible for this study, the patient must fall between 55 and 85 years old. As a comparison point, there are 44 trials that only accept individuals below 18 while 940 studies welcome those over 65."

Answered by AI